Gene · 10
Papers3,552
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,401 to 1,420 of 3,552
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A genetic database can be utilized to identify potential biomarkers for biphenotypic hepatocellular carcinoma-cholangiocarcinoma. | J Gastrointest Oncol | 2016 | 27563447 | PubTator, text mining | PubMed |
| Association of oxidative stress gene polymorphisms with presbycusis. | Gene | 2016 | 27562082 | PubTator, text mining | PubMed |
| The role of natural selection in human evolution - insights from Latin America. | Genet Mol Biol | 2016 | 27561111 | PubTator, text mining | PubMed |
| Triglyceride Treatment in the Age of Cholesterol Reduction. | Prog Cardiovasc Dis | 2016 | 27544319 | PubTator, text mining | PubMed |
| NAT2 Genotypes in Moroccan Patients with Hepatotoxicity Due to Antituberculosis Drugs. | Genet Test Mol Biomarkers | 2016 | 27541622 | PubTator, text mining | PubMed |
| Environmental tobacco smoke exposure and risk of breast cancer in nonsmoking women. An updated review and meta-analysis. | Inhal Toxicol | 2016 | 27541291 | PubTator, text mining | PubMed |
| The Non-Linear Child: Ontogeny, Isoniazid Concentration, and NAT2 Genotype Modulate Enzyme Reaction Kinetics and Metabolism. | EBioMedicine | 2016 | 27528266 | PubTator, text mining | PubMed |
| Pharmacokinetics of thrice-weekly rifampicin, isoniazid and pyrazinamide in adult tuberculosis patients in India. | Int J Tuberc Lung Dis | 2016 | 27510252 | PubTator, text mining | PubMed |
| Heritability of Caffeine Metabolism: Environmental Effects Masking Genetic Effects on CYP1A2 Activity but Not on NAT2. | Clin Pharmacol Ther | 2016 | 27509179 | PubTator, text mining | PubMed |
| RETRACTED: Combined GSTM1-Null, GSTT1-Active, GSTA1 Low-Activity and GSTP1-Variant Genotype Is Associated with Increased Risk of Clear Cell Renal Cell Carcinoma. | PLoS One | 2016 | 27500405 | PubTator, text mining | PubMed |
| rs1495741 as a tag single nucleotide polymorphism of N-acetyltransferase 2 acetylator phenotype associates bladder cancer risk and interacts with smoking: A systematic review and meta-analysis. | Medicine (Baltimore) | 2016 | 27495060 | PubTator, text mining | PubMed |
| Correlation of CpG Island Methylation of the Cytochrome P450 2E1/2D6 Genes with Liver Injury Induced by Anti-Tuberculosis Drugs: A Nested Case-Control Study. | Int J Environ Res Public Health | 2016 | 27490558 | PubTator, text mining | PubMed |
| The Impact of Anti-Epileptic Drugs on Growth and Bone Metabolism. | Int J Mol Sci | 2016 | 27490534 | PubTator, text mining | PubMed |
| Translesion Synthesis of the N(2)-2'-Deoxyguanosine Adduct of the Dietary Mutagen IQ in Human Cells: Error-Free Replication by DNA Polymerase κ and Mutagenic Bypass by DNA Polymerases η, ζ, and Rev1. | Chem Res Toxicol | 2016 | 27490094 | PubTator, text mining | PubMed |
| N-acetyltransferase 2 (NAT2) gene polymorphism as a predisposing factor for phenytoin intoxication in tuberculous meningitis or tuberculoma patients having seizures - A pilot study. | Indian J Med Res | 2016 | 27488001 | PubTator, text mining | PubMed |
| NAT2 gene polymorphism: covert drug interaction causing phenytoin toxicity. | Indian J Med Res | 2016 | 27487996 | PubTator, text mining | PubMed |
| A Physiologically Based Pharmacokinetic Model of Isoniazid and Its Application in Individualizing Tuberculosis Chemotherapy. | Antimicrob Agents Chemother | 2016 | 27480867 | PubTator, text mining | PubMed |
| HIV-1 Coinfection Does Not Reduce Exposure to Rifampin, Isoniazid, and Pyrazinamide in South African Tuberculosis Outpatients. | Antimicrob Agents Chemother | 2016 | 27480859 | PubTator, text mining | PubMed |
| Delamanid Coadministered with Antiretroviral Drugs or Antituberculosis Drugs Shows No Clinically Relevant Drug-Drug Interactions in Healthy Subjects. | Antimicrob Agents Chemother | 2016 | 27458223 | PubTator, text mining | PubMed |
| Interaction of the Chromatin Remodeling Protein hINO80 with DNA. | PLoS One | 2016 | 27428271 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10/papers?page=71